Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

15.5K
Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
15.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study.

Haematologica·2026
Same author

Leucostasis-induced limb ischaemia in acute myeloid leukaemia.

British journal of haematology·2025
Same author

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Selective ultrasound-guided nerve root block improves outcomes for discectomy in patients with cervical disc disease: a randomized, controlled, single-blinded study.

Minerva anestesiologica·2024
Same author

Inter-patient heterogeneity in the hepatic ischemia-reperfusion injury transcriptome: Implications for research and diagnostics.

New biotechnology·2023
Same author

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma.

Pathology oncology research : POR·2022
Same journal

Flat epithelial atypia of the breast: a pragmatic, context-integrated diagnostic framework within a biological continuum.

Histopathology·2026
Same journal

Myxoid neoplasms with MAP3K kinase fusion: a study of 39 cases.

Histopathology·2026
Same journal

TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinoma.

Histopathology·2026
Same journal

Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challenges.

Histopathology·2026
Same journal

A CRX-positive RB1-deficient bone tumour with a retinoblastoma-like DNA methylation profile.

Histopathology·2026
Same journal

Perivascular epithelioid cell tumours of the genitourinary tract: clinicopathological features and molecular landscape.

Histopathology·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry
09:15

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry

Published on: July 26, 2019

10.1K

A reference image-based method for optimization of clinical immunohistochemistry.

Marcel Kap1, King H Lam1, Patricia Ewing-Graham1

  • 1Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.

Histopathology
|February 3, 2015
PubMed
Summary
This summary is machine-generated.

Optimizing immunohistochemistry (IHC) protocols by adjusting analytical factors, not pre-analytical ones like cold ischaemic and formalin fixation time (CIT and FFT), improved staining consistency. This method aids in reducing interlaboratory variation for reliable IHC results.

Keywords:
FFPEcold ischaemic timeformalin fixation timeimmunohistochemistryinterlaboratory variationoptimizationpre-analytical phase

More Related Videos

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

21.8K
Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples
06:52

Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples

Published on: July 11, 2025

1.1K

Related Experiment Videos

Last Updated: Apr 18, 2026

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry
09:15

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry

Published on: July 26, 2019

10.1K
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

21.8K
Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples
06:52

Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples

Published on: July 11, 2025

1.1K

Area of Science:

  • Anatomical Pathology
  • Biochemistry
  • Immunology

Background:

  • Intralaboratory variation in immunohistochemistry (IHC) is often attributed to pre-analytical factors such as cold ischaemic time (CIT) and formalin fixation time (FFT).
  • Standardized control tissues with known pre-analytical histories are essential for method development and validation.

Purpose of the Study:

  • To develop and evaluate a novel method for optimizing IHC protocols.
  • To assess the impact of CIT and FFT on IHC staining using control tissue blocks.
  • To compare IHC outcomes with digitized reference slides for quality assessment.

Main Methods:

  • Control tissue specimens were divided and subjected to varying CIT and FFT.
  • Immunohistochemistry was performed using 34 antibodies and standard operating procedures.
  • Staining intensity was scored, and IHC protocols were adapted by modifying antibody dilution and antigen retrieval methods.

Main Results:

  • Seven antibodies were affected by CIT, 13 by FFT, and five by both.
  • Protocol optimization, primarily through analytical adjustments, improved staining consistency for most antibodies.
  • Nine protocols remained un-optimizable, but optimized results met adequate quality standards when compared to reference slides.

Conclusions:

  • Optimizing the analytical phase of IHC protocols is more effective than altering pre-analytical conditions for improving consistency.
  • This method, if supported by global references, has the potential to significantly reduce interlaboratory variation in IHC.
  • Further standardization of pre-analytical workflows is recommended to complement analytical optimization efforts.